Literature DB >> 9577524

Lung infections. 1. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection.

R A Stockley1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9577524      PMCID： PMC1758695          DOI： 10.1136/thx.53.1.58

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  16 in total

Review 1.  Leucocyte adhesion to endothelium.

Authors:  A Wardlaw
Journal:  Clin Exp Allergy       Date:  1990-11       Impact factor: 5.018

Review 2.  Bronchiectasis--a management problem?

Authors:  R A Stockley
Journal:  Br J Dis Chest       Date:  1988-07

Review 3.  Bronchiectasis--new therapeutic approaches based on pathogenesis.

Authors:  R A Stockley
Journal:  Clin Chest Med       Date:  1987-09       Impact factor: 2.878

4.  The immunological component of the cellular inflammatory infiltrate in bronchiectasis.

Authors:  J R Silva; J A Jones; P J Cole; L W Poulter
Journal:  Thorax       Date:  1989-08       Impact factor: 9.139

5.  Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state.

Authors:  R A Stockley; S L Hill; H M Morrison
Journal:  Thorax       Date:  1984-06       Impact factor: 9.139

6.  Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Authors:  K Groeneveld; L van Alphen; P P Eijk; H M Jansen; H C Zanen
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

7.  Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease.

Authors:  J D Li; A F Dohrman; M Gallup; S Miyata; J R Gum; Y S Kim; J A Nadel; A Prince; C B Basbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

8.  Cells containing IgA subclasses in bronchi of subjects with and without chronic obstructive lung disease.

Authors:  D Burnett; J Crocker; R A Stockley
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

9.  Serum IgG subclasses in chronic and recurrent respiratory infections.

Authors:  P J Stanley; G Corbo; P J Cole
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

10.  IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies.

Authors:  M Kilian; J Mestecky; R Kulhavy; M Tomana; W T Butler
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422
View more
  10 in total

Review 1.  Factors influencing airway inflammation in chronic obstructive pulmonary disease.

Authors:  A Hill; S Gompertz; R Stockley
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

2.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.

Authors:  A Bhowmik; T A Seemungal; R J Sapsford; J A Wedzicha
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

3.  Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx.

Authors:  C F Ryan; L L Love; D Peat; J A Fleetham; A A Lowe
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

4.  Inflammatory mechanisms in the lung.

Authors:  B Moldoveanu; P Otmishi; P Jani; J Walker; X Sarmiento; J Guardiola; M Saad; Jerry Yu
Journal:  J Inflamm Res       Date:  2008-12-16

5.  Gaining the Upper Hand on Pulmonary Drug Delivery.

Authors:  Jean Tyrrell; Robert Tarran
Journal:  J Pharmacovigil       Date:  2014-03-01

Review 6.  Role of antimicrobial agents in the management of exacerbations of COPD.

Authors:  Sat Sharma; Nicholas Anthonisen
Journal:  Treat Respir Med       Date:  2005

7.  Impact of statins and ACE inhibitors on mortality after COPD exacerbations.

Authors:  Eric M Mortensen; Laurel A Copeland; Mary Jo V Pugh; Marcos I Restrepo; Rosa Malo de Molina; Brandy Nakashima; Antonio Anzueto
Journal:  Respir Res       Date:  2009-06-03

8.  Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.

Authors:  Neil E Alexis; John C Lay; Angela Haczku; Henry Gong; William Linn; Milan J Hazucha; Brad Harris; Ruth Tal-Singer; David B Peden
Journal:  Environ Health Perspect       Date:  2008-06       Impact factor: 9.031

Review 9.  Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.

Authors:  Jadwiga A Wedzicha; Simon E Brill; James P Allinson; Gavin C Donaldson
Journal:  BMC Med       Date:  2013-08-14       Impact factor: 8.775

Review 10.  Protracted bacterial bronchitis: The last decade and the road ahead.

Authors:  Anne B Chang; John W Upham; I Brent Masters; Gregory R Redding; Peter G Gibson; Julie M Marchant; Keith Grimwood
Journal:  Pediatr Pulmonol       Date:  2015-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.